2 September 2024 in JNCI Cancer Spectrum
Cervical cancer-related stigma is common but understudied in the Caribbean. This study aims to describe the age difference of cervical cancer stigma and to evaluate the influence on the prevention practices among the Caribbean non-patient population in Jamaica, Grenada, Trinidad and Tobago. A cross-sectional study involving 1,209 participants was conducted using a culturally trans-created Cancer Stigma Scale for the Caribbean context and supplemented with questions on cervical cancer and HPV/HPV vaccine knowledge and beliefs. Descriptive analyses and Chi-square tests were conducted. Chi-squared tests showed age is significantly related to participants’ response to stigma items such as “community members believe cervical cancer is viewed as shameful” (p = .0001); “women with cervical cancer are treated with less respect than usual by others” (p<.0001), “women with cervical cancer are rejected by family members” (p = .0007), “women with cervical cancer are rejected by intimate partners” (p<.0001), and “intimate partners blame women for having cervical cancer” (p = .0032). Additionally, age has significant associations with endorsements of negative views of cervical cancer from the community (p<.0001) and family (p<.0001) as key barriers to cervical cancer care (item: “discourage women from seeking and obtaining screening and treatment”). Notably, younger respondents (18-25 years) are more sensitized to the unfair stigma and hold more stigma. Among Caribbeans, age influences cervical cancer stigma. Younger persons acknowledged greater stigma within families and communities. This study can guide age-informed interventions and programs to reduce stigma and improve cervical cancer screening and care seeking to reduce cervical cancer burden and disparities.
23 June 2025 in Journal of Cancer Policy
1 May 2025 in Cancer Epidemiology, Biomarkers & Prevention
Background: Globally, Caribbean countries are among the most heavily burdened by both human immunodeficiency virus and cancer. Due to their immunocompromised status, people living with human immunodeficiency virus (PLWH) are more susceptible to human papillomavirus (HPV)–related cancers. Methods: We conducted a preliminary study evaluating HPV vaccination rates targeting PLWH in Trinidad and Tobago using data from local clinics. This study provided descriptive analysis results, including demographic characteristics of enrolled PLWH and HPV vaccination rates. Results: A total of 5,615 PLWH (age ranged from 18 to 51 years, with 51.4% women and 48.6% men) were enrolled in this evaluation. Of these, 1,178 patients (21.0%) received HPV vaccines: 22.8% were vaccinated with one dose, 25.6% were vaccinated with two doses, and 51.6% were vaccinated with three doses. The highest uptake of 22.3% was in 2021, followed by 20.1% in 2022, but in 2023, it dropped to 15.5%. Between 2018 and 2020, the uptakes were 13.6% for 2020, 12.7% for 2019, and 5.7% for 2018. Conclusions: Overall, the HPV vaccination rates among PLWH in Trinidad and Tobago are low; only one in five was vaccinated. Impact: Results suggest that by implementing comprehensive and targeted programs, clinics have the potential to successfully implement HPV vaccinations toward significantly reducing the incidence and mortality of HPV-related cancers and saving lives. There is a trend with the highest vaccination uptake during the peak years of COVID-19 vaccinations, with HPV vaccination rates almost doubling between 2019 and 2021. Hence, our data suggest that the COVID-19 vaccination program may have boosted HPV vaccination.
4 January 2025 in Annals of Behavioral Medicine
Background: Black individuals in United States have the poorest outcomes in cancer and receipt of cancer screening. Purposes: This study seeks to describe cancer screening among Black subgroups, especially considering the influence on quality of life (QOL). Methods: Data from the African Cancer Prevention Project of Philadelphia (CAP3) were analyzed to examine differences among Black subgroups for QOL variables and cancer screening. Descriptive analysis and Fisher’s exact test were conducted. Results: The overall sample included 294 participants (177 African Americans, 34 US immigrants from Africa, and 83 US immigrants from Afro-Caribbean) ranging from 21 to 88 years old. Significant differences were found in various cancer screenings, such as Caribbean immigrant female participants receiving cervical cancer screening, African Americans receiving breast cancer screening, and US immigrants from Africa receiving colorectal cancer screening. Conclusions: Quality-of-life factors varied across the 3 Black subgroups and varied by cancer screening site. QOL factors have a significant impact on cancer screening. More culturally tailored cancer prevention interventions should be developed for the self-reported Black population.